Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Marti, Christophe; John, Gregor Raphaël; Konstantinides, Stavros; Combescure, Christophe; Sanchez, Olivier; Lankeit, Mareike; Meyer, Guy; Perrier, Arnaud

doi:10.1093/eurheartj/ehu218

Article scientifique

Anglais

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Contributeurs/tricesMarti, Christophe; John, Gregor Raphaël

; Konstantinides, Stavros; Combescure, Christophe

; Sanchez, Olivier; Lankeit, Mareike; Meyer, Guy; Perrier, Arnaud

Publié dansEuropean heart journal, vol. 36, no. 10, p. 605-614

Date de publication2015

Résumé

Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage. We reviewed the risks and benefits of thrombolytic therapy in the management of patients with acute PE.

Structure d'affiliation

Groupe de recherche

Citation (format ISO)

MARTI, Christophe et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. In: European heart journal, 2015, vol. 36, n° 10, p. 605–614. doi: 10.1093/eurheartj/ehu218

Article (Published version)

Identifiants

PID : unige:45634
DOI : 10.1093/eurheartj/ehu218
PMID : 24917641

ISSN du journal0195-668X

520vues

0téléchargements

Création25/11/2014 16:53:00

Première validation25/11/2014 16:53:00

Heure de mise à jour14/03/2023 22:43:53

Changement de statut14/03/2023 22:43:53

Dernière indexation16/01/2024 16:22:28

Archive ouverte UNIGE

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage. We reviewed the risks and benefits of thrombolytic therapy in the management of patients with acute PE.

Informations techniques